André Talvani

In vitro and in vivo experimental models for drug screening and development for Chagas disease

Álvaro J. Romanha, Solange L. de Castro, Maria de Nazaré Correia Soeiro et al. · Memórias do Instituto Oswaldo Cruz · 2010 · 349 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with

André Talvani, Cristiana S Ribeiro, Júlio Aliberti et al. · Microbes and Infection · 2000 · 181 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Fexinidazole: A Potential New Drug Candidate for Chagas Disease

Maria Terezinha Bahia, Isabel Mayer de Andrade, Tassiane Assíria Fontes Martins et al. · PLoS neglected tropical diseases · 2012 · 180 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +15

Elevated Concentrations of CCL2 and Tumor Necrosis Factor–α in Chagasic Cardiomyopathy

André Talvani, Manoel Otávio da Costa Rocha, Lucíola S. Barcelos et al. · Clinical Infectious Diseases · 2004 · 134 citations

Medicine, Cardiology, Pathology +14

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments

Lívia de Figueiredo Diniz, Julio A. Urbina, Isabel Mayer de Andrade et al. · PLoS neglected tropical diseases · 2013 · 121 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17